Product Images Pregabalin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 14 images provide visual information about the product associated with Pregabalin NDC 60760-591 by St. Mary's Medical Park Pharmacy, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
60760-591 - PREGABALIN 60760 591 60
This is a medication label for Pregabalin capsules, in 100mg strength and quantity of 60. The product is manufactured by ScieGen Pharmaceuticals, Inc. and packaged by S, StManys in Arizona. It includes an RX number, but lot numbers and expiration dates are partially obscured. The label instructs users to use as directed and store the medication at room temperature.*
Figure 1 - pregabalin fig01
Figure 2 - pregabalin fig02
This appears to be a chart indicating the percentage of patients who improved after taking Pregabalin at a dosage of 160mg for three days. The chart also includes numerical values for improvement in pain. However, the chart is not clear and there are some legibility issues with the text.*
Figure 3 - pregabalin fig03
This appears to be a record of medication regimens and their effectiveness in improving pain levels for patients. The first section shows the percent of patients who improved with different doses of Pregabalin, while the second section shows the percent improvement in pain from baseline for an unknown medication. No further information is available.*
Figure 4 - pregabalin fig04
Figure 5 - pregabalin fig05
This is a report on the effectiveness of three medicines - Fregabalin, Pregataiin and Placebo - in improving pain in patients. The doses administered are mentioned as 100 mg of Fregabalin thrice a day, 80 mg of Pregataiin thrice a day and Placebo with unknown dosage. The report contains a chart showing the percentage of patients improved, which is followed by another chart showing the percentage improvement in pain from baseline.*
Figure 6 - pregabalin fig06
Figure 7 - pregabalin fig07
Figure 9 - pregabalin fig08
This is a graph that shows the percentage of patients who improved while taking Pregabalin in doses of 300mg and 450mg per day, compared to a placebo. The X-axis represents the percentage improvement in pain from baseline, while the Y-axis represents the number of patients. There is no additional information available to create a more detailed description.*
Figure 10 - pregabalin fig09
This appears to be a table or chart displaying the percentage of subjects without LTR (Long-Term Relapse) over a period of time, with 0-100% listed at intervals of 10%. There are two categories listed, "Progabain" and "Placebo," and a timeline ranging from 0 to 180 days. Not much additional information can be gleaned from this text without further context.*
Figure 11 - pregabalin fig10
Figure 12 - pregabalin fig11
Cockcroft and Gault equation - pregabalin formula
This appears to be a formula for calculating CLCT (creatinine clearance) in a patient based on their age, weight, and serum creatinine levels. The formula involves subtracting the patient's age in years from 140, multiplying that result by the patient's weight in kilograms, then multiplying the product by 0.85 for female patients. The result is then divided by 72 multiplied by the patient's serum creatinine level in milligrams per deciliter.*
Chemical Structure - pregabalin str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.